Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Long-Term Debt Issuances
Ratios

Vycor Medical (VYCO) EBIAT (2022 - 2023)

Vycor Medical (VYCO) has disclosed EBIAT for 6 consecutive years, with -$51479.0 as the latest value for Q3 2023.

  • Quarterly EBIAT rose 54.16% to -$51479.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$85431.0 through Sep 2023, up 89.56% year-over-year, with the annual reading at -$2.9 million for FY2012, 38.76% up from the prior year.
  • EBIAT for Q3 2023 was -$51479.0 at Vycor Medical, down from $70791.0 in the prior quarter.
  • The five-year high for EBIAT was $70791.0 in Q2 2023, with the low at -$112312.0 in Q3 2022.